+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Association of Prescription Drug Price Rebates in Medicare Part D With Patient Out-of-Pocket and Federal Spending

Association of Prescription Drug Price Rebates in Medicare Part D With Patient Out-of-Pocket and Federal Spending

JAMA Internal Medicine 177(8): 1185-1188

The increasing cost of prescription drugs is a burden for patients and threatens the financial stability of the US health care system. Rebates are a form of price concession paid by a pharmaceutical manufacturer to the health plan sponsor or the pharmacy benefit manager working on the plan's behalf. Proponents argue that rebates result from vigorous negotiations that help lower overall drug costs. Critics argue that rebates have perversely increased the costs patients pay out of pocket, as well as the costs for Medicare as a whole. This special communication discusses how the availability of rebates for drugs covered by the Medicare Part D program may raise costs for patients and Medicare while increasing the profits of Part D plan sponsors and pharmaceutical manufacturers. Two policy alternatives are herein proposed that would reconfigure cost sharing to lower patient out-of-pocket costs and reduce cost shifting to Medicare.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 059415807

Download citation: RISBibTeXText

PMID: 28558108

DOI: 10.1001/jamainternmed.2017.1885

Related references

Closing the Medicare Doughnut Hole: Changes in Prescription Drug Utilization and Out-of-Pocket Spending Among Medicare Beneficiaries With Part D Coverage After the Affordable Care Act. Medical Care 55(1): 43-49, 2016

Do Medicare Advantage Rebates Reduce Enrollees' Out-of-Pocket Spending?. Medical Care Research and Review 2018: 1077558718807847, 2018

Generic Drug Price Hikes And Out-Of-Pocket Spending For Medicare Beneficiaries. Health Affairs 37(10): 1578-1586, 2018

National trends in out-of-pocket prescription drug spending among elderly medicare beneficiaries. Expert Review of Pharmacoeconomics and Outcomes Research 5(3): 297-315, 2005

The impact of the medicare part D prescription drug benefit on prescription utilization and out-of-pocket expenditures. Journal of Investigative Medicine 56(3): 620, 2008

Analysis of national annual variation in total patient out-of-pocket Medicare Part D stand-alone prescription drug plan costs from 2007 to 2008. Journal of Medical Economics 11(4): 625-637, 2009

Effects of Medicare Part D on drug affordability and use: Are seniors with prior high out-of-pocket drug spending affected more?. Research in Social and Administrative Pharmacy 6(2): 90-99, 2010

Impact of Medicare Part D for Medicare-age adults with arthritis: prescription use, prescription expenditures, and medical spending from 2005 to 2008. Arthritis Care and Research 64(9): 1423-1429, 2012

How the Medicare Part D drug benefit changed the distribution of out-of-pocket pharmacy spending among older beneficiaries. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences 65(4): 502-507, 2010

Analysis of Proposed Medicare Part B to Part D Shift With Associated Changes in Total Spending and Patient Cost-Sharing for Prescription Drugs. JAMA Internal Medicine 2019, 2019

Has Medicare Part D reduced racial/ethnic disparities in prescription drug use and spending?. Health Services Research 49(2): 502-525, 2014

The Effect of Medicare Part D on Prescription Drug Spending and Health Care Use: 6 Years of Follow-up, 2007-2012. Journal of Managed Care & Specialty Pharmacy 23(1): 5-12, 2017

The Impact of Medicare Part D on the Proportion of Out-of-Pocket Prescription Drug Costs Among Older Adults With Diabetes. Diabetes Care 40(4): 502-508, 2016

The New Medicare Part D Prescription Drug Benefit: An Estimation of Its Effect on Prescription Drug Costs in a Medicare Population with Atrial Fibrillation. Yearbook of Cardiology 2008: 498-499, 2008

The new Medicare Part D prescription drug benefit: an estimation of its effect on prescription drug costs in a Medicare population with atrial fibrillation. Journal of the American Geriatrics Society 55(7): 1038-1043, 2007